Board Meeting8 Oct 2026, 05:30 pm
Mankind Pharma Board Meeting on Oct 26 for Q2 FY27 Results
AI Summary
Mankind Pharma Ltd has announced that its Board of Directors will convene on October 26, 2026. The primary agenda item is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Additionally, the trading window for the company's securities will remain closed until October 28, 2026, in line with insider trading regulations.
Key Highlights
- Board meeting scheduled for October 26, 2026.
- To approve unaudited standalone and consolidated results.
- Results for the quarter and half-year ended September 30, 2026.
- Trading window closure extended until October 28, 2026.
Price Impact
More from MANKIND